Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Advances in Experimental Medicine and Biology|June 16, 2019
Clinical and Pre-clinical Methods for Quantifying Tumor HypoxiaAshlyn G Rickard, Gregory M Palmer, Mark W DewhirstBiomedical Optics Express|August 22, 2022
Quantifying the effects of anesthesia on intracellular oxygen via low-cost portable microscopy using dual-emissive nanoparticlesAshlyn G Rickard, Meng Zhuang, Christopher A DeRosa, et al.Journal of Biomedical Optics|November 24, 2020
Dual-emissive, oxygen-sensing boron nanoparticles quantify oxygen consumption rate in breast cancer cellsAshlyn G Rickard, Meng Zhuang, Christopher A DeRosa, et al.Plos One|August 27, 2020
Cherenkov emissions for studying tumor changes during radiation therapy: An exploratory study in domesticated dogs with naturally-occurring cancerAshlyn G Rickard, Hiroto Yoshikawa, Gregory M Palmer, et al.Current Oncology (Toronto, Ont.)|March 28, 2023
A Clinical Study to Assess Diffuse Reflectance Spectroscopy with an Auto-Calibrated, Pressure-Sensing Optical Probe in Head and Neck CancerAshlyn G Rickard, Husam Mikati, Antoine Mansourati, et al.Bioconjugate Chemistry|January 12, 2019
Targeting Fluorescent Nanodiamonds to Vascular Endothelial Growth Factor Receptors in TumorMarco D Torelli, Ashlyn G Rickard, Marina V Backer, et al.Cancers|May 16, 2023
A Novel Preclinical Murine Model to Monitor Inflammatory Breast Cancer Tumor Growth and Lymphovascular InvasionAshlyn G Rickard, Dorababu S Sannareddy, Alexandra Bennion, et al.Frontiers in Immunology|November 12, 2024
Computational staining of CD3/CD20 positive lymphocytes in human tissues with experimental confirmation in a genetically engineered mouse modelXiang Li, Casey C Heirman, Ashlyn G Rickard, et al.Molecular Imaging and Biology|September 18, 2023
Evaluating Tumor Hypoxia Radiosensitization Via Electron Paramagnetic Resonance Oxygen Imaging (EPROI)Ashlyn G Rickard, Yvonne M Mowery, Alex Bassil, et al.International Journal of Radiation Oncology, Biology, Physics|December 17, 2023
Preclinical Evaluation of the ATR Inhibitor BAY 1895344 as a Radiosensitizer for Head and Neck Squamous Cell CarcinomaDiana A Odhiambo, Allison N Pittman, Ashlyn G Rickard, et al.Pageof 1